Brian Barnett, MD is an Assistant Professor of Psychiatry at Cleveland Clinic Lerner College of Medicine and Clinical Director of the Psychiatric Treatment-Resistance Program at Cleveland Clinic. Dr. Barnett completed his psychiatry residency at Massachusetts General Hospital and McLean Hospital in 2017. Afterwards, he completed his fellowship in addiction psychiatry at Partners Healthcare in 2018 and a fellowship in forensic psychiatry at University Hospitals/Case Western Reserve University in 2019. Dr. Barnett’s primary research interests are in catatonia, mood disorders, psychedelics, and psychedelic-assisted therapy. He is the principal investigator on clinical trials assessing the efficacy of LSD for generalized anxiety disorder and psilocybin-assisted therapy for treatment-resistant depression. Dr. Barnett also writes about mental health and addiction issues for the public, and his writing has been featured in Huffington Post, the Wall Street Journal, the Washington Post, and other outlets.